- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Apr 23, 2025 | 7.97M sh |
| Shares Diluted restated | FY 2025 · Jan 31, 2024 | 1.41K sh |
| Capex restated | FY 2025 · Jan 31, 2024 | $290K |
| Operating Cash Flow | FY 2025 · Jan 31, 2024 | −$4.97M |
| Cash And Equivalents | FY 2025 · Jan 31, 2024 | $5.29M |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $10.28M |
| Total Liabilities | FY 2025 · Jan 31, 2024 | $10.85M |
| Current Assets | FY 2025 · Jan 31, 2024 | $28.34M |
| Total Assets | FY 2025 · Jan 31, 2024 | $33.49M |
| Eps Basic | FY 2025 · Jan 31, 2024 | −$2.50 |
| Sga Expense | FY 2025 · Jan 31, 2024 | $12.14M |
| Rd Expense | FY 2025 · Jan 31, 2024 | $2.13M |
| Net Income | FY 2025 · Jan 31, 2024 | $274K |
| Operating Income | FY 2025 · Jan 31, 2024 | $518K |
| Gross Profit | FY 2025 · Jan 31, 2024 | $15.97M |
| Revenue | FY 2025 · Jan 31, 2024 | $36.51M |
| Stockholders Equity | FY 2025 · Jan 31, 2023 | $23.05M |